Condition: Schizophrenia · Schizoaffective Disorder · Sponsor: New York State Psychiatric Institute
Two-hundred and eighty individuals with schizophrenia who have a recent history of violent acts will be randomized in this 2-arm, parallel-group, 24-week, open-label, 7-site clinical trial to examine the effects of treatment with clozapine vs antipsychotic treatment as usual (TAU) for reducing the risk of violent acts in real-world settings
This description comes directly from the study's public registry record.
Ragy Girgis · 646-774-5553 · ragy.girgis@nyspi.columbia.edu
Always discuss trial participation with your own doctor first.
| University of California, Los Angeles | Los Angeles, California, United States | Recruiting |
| Augusta University Research Institute, Inc. | Augusta, Georgia, United States | Recruiting |
| University of Maryland School of Medicine | Baltimore, Maryland, United States | Recruiting |
| NYU Langone Medical Center | New York, New York, United States | Recruiting |
| New York State Psychiatric Institute | New York, New York, United States | Recruiting |
| Manhattan Psychiatric Center | New York, New York, United States | Recruiting |
| University of North Carolina at Chapel Hill | Chapel Hill, North Carolina, United States | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT05208190